Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

NCT04299191 is registered in ClinicalTrials.gov with Laminar Pharmaceuticals as lead sponsor.

NCT NCT04299191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Lead sponsor
Laminar Pharmaceuticals
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 1, 2020
Completion date
December 31, 2026
Enrollment
28 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade glioma, solid tumor, unspecified, child